Showing results (981-990 of 4,124) with videos related to
Sort By:
Pageof 413
Human Gene Therapy|June 4, 2024
Insights into Prime Editing Technology: A Deep Dive into Fundamentals, Potentials, and ChallengesSeyed Younes Hosseini, Rahul Mallick, Petri Mäkinen, et al.Human Gene Therapy|July 13, 2024
The Legal Status and Improvement Path of Human Genetic Data in Gene Therapy in ChinaJiajv Chen, Wei LiHuman Gene Therapy|December 29, 2025
Brain-Directed AAV Gene Therapy Rescues a Mouse Model of the CLN5 Form of Neuronal Ceroid Lipofuscinosis Disease and Normalizes a Blood Plasma Biomarker of NeurodegenerationWenfei Liu, Amy F Geard, Giulia Massaro, et al.Human Gene Therapy|November 21, 2025
Stable and Predictable Lentiviral Vector Production at Clinical ScaleNiels Heinz, Laura Mosbacher, Lisa C Cordie, et al.Human Gene Therapy|November 20, 2025
Regulatory Perspective for Biologics License Application of Recombinant Adeno-Associated Virus Products in ChinaJing Cui, Wenbo Wang, Dan Liu, et al.Human Gene Therapy|December 21, 2023
Prophylactic Prednisolone Promotes AAV5 Hepatocyte Transduction Through the Novel Mechanism of AAV5 Coreceptor Platelet-Derived Growth Factor Receptor Alpha Upregulation and Innate Immune SuppressionBritta Handyside, Lening Zhang, Bridget Yates, et al.Human Gene Therapy|January 12, 2018
Current Status of Nonviral Vectors for Gene Therapy in ChinaLi Liu, Jingyun Yang, Ke Men, et al.Human Gene Therapy|April 9, 2021
Intravitreal Injection of an Exosome-Associated Adeno-Associated Viral Vector Enhances Retinoschisin 1 Gene Transduction in the Mouse RetinaWeiping Wang, Jingyang Liu, Mingzhu Yang, et al.Human Gene Therapy|August 3, 2026
Accelerating Translation of NK Cell Therapies to the Clinic: A European PerspectiveLea Rebecca Knapp, Katharina Sophie Fischer, Janika Sosat, et al.Human Gene Therapy|December 14, 2022
Lifelong Outcomes of Systemic Adeno-Associated Virus Micro-Dystrophin Gene Therapy in a Murine Duchenne Muscular Dystrophy ModelNalinda B Wasala, Yongping Yue, Bryan Hu, et al.Pageof 413